Tender Details
Ref No 7164900
Document

Tender Notice

Bidding

Not specified

Short Description

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab (Exclusively In Dafo. Injection Solution, Atc L04Aa23 (Obo) For The Period 01.09.24 - 31.08.26

Deadline *
Date 05 Jul 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Germany
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

Ship Propulsion Fuel Bunkers

Career Paths Construction Technology And Green

Drug Contracts With An Option To Join

Openhouse Procedure Dressing Materials

Career Paths Transport And Logistics